Conditions · Alzheimer's disease & early-stage dementia
Alzheimer's disease & early-stage dementia — frontier options in Minnesota
19 open options
- TRIALNARECRUITING
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
F-18 AV 1451 · C-11 PiB — 1 site
- TRIALPHASE4ENROLLING_BY_INVITATION
MIBG in Aging and Neurologic Disorders
meta-iodobenzylguanidine (MIBG) (123I) · 123I-MIBG scintigraphy — 1 site
- TRIALPHASE3RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Xanomeline/Trospium Chloride Capsule · Xanomeline Enteric Capsule · Placebo — 145 sites
- TRIALNARECRUITING
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
Active tDCS and Cognitive Training Intervention · Sham tDCS and Cognitive Training Intervention — 2 sites
- TRIALNARECRUITING
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
Cognitive Training · Computerized Cognitive Stimulation — 6 sites
- TRIALPHASE4RECRUITING
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
18-F-Flortaucipir — 2 sites
- TRIALPHASE4ENROLLING_BY_INVITATION
Imaging of Brain Amyloid Plaques in the Aging Population
Pittsburgh Compound B (C-11 PiB) · F-18 FDG · Tau (18-F-AV-1451) — 1 site
- TRIALNANOT_YET_RECRUITING
A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement
Social Reminder System — 1 site
- TRIALPHASE3RECRUITING
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Acoramidis · Placebo oral tablet — 104 sites
- TRIALNAENROLLING_BY_INVITATION
TMS Pilot in Early AD II
Intermittent theta burst stimulation active coil · Sham coil — 1 site
- TRIALNARECRUITING
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
MRI screening form · Urine pregnancy test · MR brain — 1 site
- TRIALPHASE2RECRUITING
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Donanemab · Placebo — 72 sites
- TRIALPHASE2ENROLLING_BY_INVITATION
Neuroimaging Study
Tau PET scan — 2 sites
- TRIALPHASE2ENROLLING_BY_INVITATION
Tau PET Outcomes With Anti-amyloid Immunotherapies
18F-AV-1451 — 1 site
- TRIALNANOT_YET_RECRUITING
An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
Insole and ankle device — 1 site
- TRIALPHASE4ENROLLING_BY_INVITATION
DaTSCAN Imaging in Aging and Neurodegenerative Disease
I-123 Ioflupane solution injection prior to SPECT scan (DaTscan) · Single photon emission computed tomography (SPECT) scan — 1 site
- TRIALPHASE3RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
KarXT · KarX-EC · Placebo — 119 sites
- TRIALPHASE3RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
KarXT · KarX-EC — 256 sites
- TRIALPHASE2ENROLLING_BY_INVITATION
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
C-11 ER-176 · Blood Test — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.